icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
eNq1mF1v2jAUhu/5FVHuSUg/oEyBamOwIbUao0WbdlOZ5ABmwU6PbaD79XMI3ejkqKvBl7Gd95z4vH58lPh6u8q8NaCgnHX8KGj4HrCEp5TNO/7kflC/8q+7tXhJ1uRgWStoBNGZ7yUZEaLjF7PBFAgTwffbm4+g3wf0uzUv5tMlJPLFOiVpFnwmYnFL8mKNF685Tb0VyAVPO36u5G7Ui4VEnUV3w/GnyEkCcbgfOZxdPlwcjsdhIfYfqkoA3hA2N4oCs9JMFCIw2SMS5hyfKvI9t9KmYgyCK0xgRORihHxNU0iNIWYkE2AVZLZJ7wDXGcgiiFE8XCYrYSVOlmQ7hsehOen3erYnt7LeqEet5kX7ot1ut6JWyyoUHmyVuQr6I8LkITpvRu1mIwQWMlgTRhLL2ow4SpI5qgoVvZfGchQH4fHV6qdU5Bl5CpYit90qgkRPA+rj7+5Dii+4Rw2kTO/ZP/pMZVn4xqwne1w4yrigUY8rJiuoMRjbbkSPMwnb6oragU5u916kIE4n+4szM+RHaprRxBZpGjoKhJyMh9VEOyUMPhABE3RHg2+UpXwjTk+Zw6o6yj7fgdIommMaPZy1r5rR5aX1IfqhLVRxw/QV8hxCzR8qjsHKkM34sUDRrjRLPXvyZHbc9Tk8IRlUdDp1S7ZoHz43Zs6c7u4UlRNG0U/9e1t7fFWAT3e7R6M0TTt/CmsHXhc012asTPzt1i5PuJMeWKGZHAspc/EuDDebTbAgoi6I3qVghicn+8Fl6q4Dd3Jjlx1MSUdHqU/La+9tFbI9aa/d6cf2qfv39/2wMYZEBUfUooSyM3QO+6en8d8m1Vnaoxf0cBdm11ASSTlz1eioqVHxOP7rurIBakB8mc1oxR+RSl/GYfk3pluLw+JPTLf2G7DI5HI=
2eX84d5uutuyKy7e